baber/WOPTO huggingface dataset:
Patent NZ-542586-A (NZ)
Title: Method of forming a covalent conjugate between a G-CSF peptide and PEG
Inventor: DE FREES SHAWN
IPC: C07K/
Filed: 2004-04-09
Abstract: Disclosed is a cell-free in vitro method of forming a covalent conjugate between a G-CSF peptide and poly(ethylene glycol), wherein said poly(ethylene glycol) has a molecular weight of 20kDa, and wherein said poly(ethylene glycol) is covalently attached to said G-CSF peptide via a glycosyl linking group, said method comprising contacting said G-CSF peptide with a mixture comprising a nucleotide sugar covalently linked to said poly(ethylene glycol) and a glycosyltransferase for which said nucleotide sugar is a substrate under conditions sufficient to form said conjugate. Conjugates formed according to this method can be used to stimulate proliferation differentiation and activation of neutropoietic progenitor cells.
Patent NZ-548270-A (NZ)
Title: An electrical switchboard cabinet assembly with mounted electrical devices movable with at least two degrees of freedom on sets of rails
Inventor: GREENHALGH DOUGLAS DAVID
Filed: 2006-07-03
Abstract: An electrical cabinet assembly including a movable mounting arrangement to which electrical devices may be attached. The movable mounting arrangement may be repositioned horizontally or vertically within the cabinet using releasable fasteners sliding in pairs of horizontal and vertical rails. The cabinet door provides a plurality of removable plates, any of which may be removed to provide access to electrical devices within the cabinet when the door is closed. Also provided is a kit of parts for assembling the cabinet.
Patent NZ-549643-A (NZ)
Title: Methods of forming lipid membrane attached linkers comprising contacting membrane with an oligonucleotide having two or more hydrophobic anchoring moieties
Inventor: PFEIFFER INDRIATI
IPC: C12Q1/68
Filed: 2005-02-28
Abstract: Methods of forming lipid membrane oligonucleotide attachments are provided, comprising contacting a lipid membrane with an oligonucleotide having two or more hydrophobic anchoring moieties. Said moieties may be attached at the terminal ends of an oligonucleotide or, in the case of a first and second strand forming a duplex, at the same terminal end one of the strands leaving the other end not being part of the duplex free to hybridize to additional strands. The lipid vesicles attached with the oligonucleotide can be used in biosensors and may contain membrane proteins.
Patent NZ-550008-A (NZ)
Title: Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as FAAH enzyme inhibitors
Inventor: ABOUABDELLAH AHMED
IPC: C07D217/14
Filed: 2005-02-25
Abstract: The disclosure relates to enzyme inhibitors and their use in the treatment and therapy of a wide variety of diseases and degenerative conditions. More particularly, it is directed towards the use of heteroaryl-alkylcarbamate derivatives of formula (I), processes for their preparation and methods of use thereof as fatty acid amido hydrolase (FAAH) enzyme inhibitors in the treatment of arthritis, heart disease, cancer and the like and to their application in a wide variety of therapeutic regimens such as for the treatment of pain, inflammation, neurodegenerative diseases, etc.
Patent NZ-551201-A (NZ)
Title: Pallet and method for manufacturing the same
Inventor: WONG TECK TIN
IPC: B65D65/46
Filed: 2005-04-01
Abstract: A pallet and a method for manufacturing the same are provided. The pallet comprises a pallet body, a skid to reinforce the pallet body and means to interlock the pallet body and the skid. The pallet body and the skid are moulded from a mouldable composition comprising between about 40 to 60 wt % of a fibre mixture and between about 15 to 45 wt % of an adhesive. The method for manufacturing the pallet begins by preparing the mouldable composition. A mould cavity is loaded with the mouldable composition up to about 90 % of the capacity of the mould cavity before applying a packing pressure of between about 435 to 870 psi to the mouldable composition. A predetermined clearance of between about 0.1 to 0.5 mm is maintained between a first mould part defining the mould cavity and a second mould part.; A moulded product is removed from the mould cavity when the mouldable composition is substantially cured.
Patent NZ-551911-A (NZ)
Title: Bone plate with at least one hole having three regions where a middle region of the hole is threaded and the other regions of the hole are non-threaded
Inventor: GRADY MARK P
IPC: A61B17/80
Filed: 2005-05-19
Abstract: A bone plate is disclosed which comprises a monolithic plate body having an upper surface and a lower surface, and at least one hole extending through the monolithic plate body from the upper surface to the lower surface. The hole includes three regions, including first, second, and third regions, separated from one another along a length of the hole. The first and third regions of the hole are non-threaded, and the second middle region of the hole, which is between the first and third regions, is threaded. The threaded second region is configured and dimensioned to lock a mating fastener within the hole at an angle relative to a central axis of the hole.
Patent NZ-553689-A (NZ)
Title: Device for cutting, turning, and translating a pasty or granular material
Inventor: LUBOSCHIK ULRICH
IPC: F26B1/00
Filed: 2005-08-22
Abstract: A slicing, raking and turning device includes a rotary shaft (2) supported above a layer (C) of material, transversely to the translation direction (A) of the material, rake blades (3) for turning the material extending at least partly radially relative to the shaft (2) and rotated by said shaft to penetrate into the layer, and cutter blades (4) for cutting the layer (C) of material, radially spaced apart (g) from the rotary shaft (2) and rotated by said shaft, the cutting blades(4) being located substantially on a cylindrical surface sharing a common geometrical axis with the rotary shaft, and capable, upon penetration into the layer, of fragmenting the latter, while the rake blades cause the fragmented material to be granulated.
Patent NZ-554544-A (NZ)
Title: A core for a roll of paper
Inventor: MILTON PETER GEORGE
IPC: B65H75/18
Filed: 2005-09-23
Abstract: Disclosed is a core for a roll of material. The core includes a body portion, a first end member which is removably secured to a first end of the body portion, a first bore through the first end member, a second end member which is removably secured to a second end of the body portion, a second bore through the second end member and a third bore through the body portion. The first, second and third bores all have a common longitudinal axis. The first and second bores have a smooth inner surface so as to receive respective chucks. Centering of the respective chucks is facilitated by the smooth inner surface of the first and second bores. The body portion is made solely of a metal and the first and second end members are each made of a plastics material. The first and second end members each have a flange which abuts against the respective first and second ends of the body portion. The first and second flanges and the body portion all having the same outside diameter.
Patent NZ-556525-A (NZ)
Title: Stopcock closure plug made from theroplastic elastomer (TPE)
Inventor: INDIGNE MARK
Filed: 2005-01-03
Abstract: A stopcock assembly for controlling the passage of fluids is disclosed. The stopcock comprises a housing (2) with an inlet (3) and an outlet (4) access and a closure plug (1). The closure plug (1) has a spindle nut (9) and a closure membrane (6) adhering to it. The closure membrane (6) controls the passage between the inlet (3) and outlet (4), characterized in that said closure membrane (6) is made of thermoplastic elastomer (TPE).
Patent NZ-566495-A (NZ)
Title: Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands
Inventor: RAMAKRISHNA VENKATA SATYA NIROGI
IPC: A61K31/4523
Filed: 2005-10-26
Abstract: Disclosed is a compound having the Formula (I) or a pharmaceutically acceptable salt thereof wherein R5 and R6 represent H or methyl and wherein the rest of the substituents are disclosed in the specification. Also disclosed is a process for the preparation of a compound of Formula (I) and the use of a compound of Formula (I) in the manufacture of a medicament for the treatment of a disorder of the central nervous system related to or affected by the 5-HT6 receptor.
Patent NZ-568978-A (NZ)
Title: Process flavours with low acrylamide involving yeast and asparaginase [EC 3.5.1.1]
Inventor: KORTES JAN GERRIT
IPC: A23L33/145
Filed: 2006-12-22
Abstract: Disclosed is a method to produce a yeast extract, autolysed yeast or protein hydrolysate comprising treatment of a starting yeast extract, a starting autolysed yeast or a starting protein hydrolysate containing free asparagine with asparaginase [EC 3.5.1.1]. The disclosed asparaginase [EC 3.5.1.1] used in the method is capable of reducing the amount of free asparagine in the yeast extract, autolysed yeast or protein hydrolysate, to obtain an amount of free asparagine in the yeast extract, autolysed yeast or protein hydrolysate which is not higher than 1 mg/g based on dry matter.
Patent NZ-580159-A (NZ)
Title: Lightweight input/output protocol
Inventor: MOHAMED AHMED H
IPC: G06F/
Filed: 2004-07-26
Abstract: A method for managing buffers in an input/output offload protocol comprises a server sending a delta credit message to a client. The delta credit message includes an information field set to a number of credits. If the number of credits is a negative number -N, the server requires the client to retire N credits. If the number of credits is a negative number -N, the client sends N credit messages to the server and otherwise the client sends one credit message to the server. For each credit message sent by the client, the server sends a status response message to the client. (62) Divided Out of 540173
Patent NZ-580181-A (NZ)
Title: A latching mechanism with a controllable actuator for use in a slide mechanism used to mount drawers.
Inventor: OSTROWSKI ERIC ALLEN
IPC: E05B65/46
Filed: 2008-03-28
Abstract: A latching mechanism (20) is particularly suited for use in latching a slide mechanism (OS, IS), such as used to slidably mount a drawer. The latching mechanism includes a latch assembly (24) comprising a latch lever (27) mounted for movement between a first, second and third positions, a latch tab for selective engagement with a second end of the latch lever, and a controllable actuator (22). The actuator has a plunger (66) configured to selectively control the movement of the latch lever (27) between the first and second positions, the plunger movable between an extended position corresponding to a first, locked position of the latch lever (27) and a retracted position corresponding to the second, unlocked position of the latch lever. The controllable actuator (22) when unpowered prevents the plunger (66) from moving from the extended to the retracted position and the actuator (22) when powered permitting the plunger (66) to move from the extended to the retracted position.
Patent NZ-580232-A (NZ)
Title: A method of making processed cheese comprising acidifying a reduced-fat milk and adding glycerides
Inventor: LUCEY JOHN A
IPC: A23C19/00
Filed: 2008-04-16
Abstract: Disclosed is a method for making processed cheese, comprising: a) acidifying a reduced-fat milk source to a pH of between about 5.4 and about 5.8 to obtain a cheese base comprising particles; and b) adding between about 0.4 wt.percent to about 8 wt.percent glycerides to the cheese base to obtain processed cheese, wherein the glycerides comprise between about 40 percent to about 80 percent of monoglycerides relative to the amount of glycerides and between about 20 percent to about 60 percent of diglycerides relative to the amount of glycerides.
Patent NZ-582576-A (NZ)
Title: Seamless capsule comprising gelatin and a plasticizer
Inventor: UCHIYAMA YOSHIHIRO
IPC: A61P9/00
Filed: 2008-06-27
Abstract: Disclosed is a method of producing a seamless capsule comprising a shell formed by a shell composition comprising gelatin and a plasticizer, the shell composition does not comprise an interfacial tension modifier that is a substance that changes the tension produced in the oil-water interface between the capsule content and the aqueous shell composition solution and a gelling agent, and a capsule content without comprising an interfacial tension modifier and a gelling agent by a drip in oil method, wherein temperatures of the capsule content without comprising an interfacial tension modifier and a gelling agent, the aqueous shell composition solution formed by a shell composition comprising gelatin and a plasticizer, the shell composition does not comprise an interfacial tension modifier and a gelling agent and the carrier liquid that is one or more oily substrates selected from medium-chain triglyceride (MCT) oil, olive oil, soybean oil, and corn oil are each controlled near multiple nozzles of an apparatus used for the drop in oil method, wherein the temperature of the capsule content without comprising an interfacial tension modifier and a gelling agent is controlled to a value set ± 2 degrees C within the range of 5 degrees C - 25 degrees C, wherein the temperature of the aqueous shell composition solution formed by a shell composition comprising gelatin and a plasticizer, which does not comprise an interfacial tension modifier and a gelling agent is controlled to a value set ± 2 degrees C within the range of 50 degrees C - 80 degrees C, wherein the temperature of the carrier liquid is controlled to a value set ± 1 degrees C within the range of 1 degrees C - 15 degrees C, wherein a difference between the temperature of the capsule content without comprising an interfacial tension modifier and a gelling agent and the temperature of the aqueous shell composition solution formed by a shell composition comprising gelatin and a plasticizer, which does not comprise an interfacial tension modifier and a gelling agent is not less than 25 degrees C and not more than 75 degrees C, wherein a difference between the temperature of the aqueous shell composition solution formed by a shell composition comprising gelatin and a plasticizer, which does not comprise an interfacial tension modifier and a gelling agent and the temperature of the carrier liquid is not less than 35 degrees C and not more than 79 degrees C.
Patent NZ-583028-A (NZ)
Title: Nucleic acids and proteins from streptococcus groups A & B
Inventor: TELFORD JOHN
IPC: C07K14/315
Filed: 2001-10-29
Abstract: Disclosed are proteins from group B streptococcus (Streptococcus agalactiae) and group A streptococcus (Streptococcus pyogenes). Also disclosed are antibodies that bind to the proteins; nucleic acid molecules that encode the proteins; a method to produce the proteins; methods to identify and isolate compounds that bind to the proteins; hybrid proteins; and immunogenic vaccine compositions that comprise the proteins, nucleic acid molecules or antibodies to treat or prevent infection or disease caused by a streptococcus bacterium.
Patent NZ-585118-A (NZ)
Title: Honey products with either a high or low arabinogalactan content, and the use of both to affect inflammation
Inventor: SIMS IAN
IPC: A23L21/25
Filed: 2011-05-05
Abstract: A honey isolate containing type II arabinogalactan (AG), wherein the average molecular weight of the AG is 40,000 to 1,100,000 is disclosed, wherein the ratio of arabinose to galactose in the honey isolate may range from 0.1 to 2.0 parts arabinose to 1.0 parts galactose. Further disclosed is a method of producing a honey based immune-stimulatory composition by the steps of: (a) testing a series of honey batches for the presence of type II AG compounds; (b) selecting and blending together honeys based on the test results; and (c) isolating type II AG compounds from the honey and then processing the honey by steps selected from filtration, ultra-filtration, reverse osmosis, solvent extraction, precipitation, or combinations thereof and collecting a high molecular weight isolate from the processing step to form a honey blend with type II AG levels greater than 5 microgram/gram. The disclosure also relates to the use of a honey or a honey analogue based composition with type II AG compounds removed from the honey or a honey analogue in the manufacture of a topical formulation for treatment of a recalcitrant skin condition on a topical body area, a sensitive skin condition on a topical body area.
Patent NZ-587363-A (NZ)
Title: 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists
Inventor: BLASKOVICH MARK ARNOLD THOMAS
IPC: A61K31/551
Filed: 2009-02-27
Abstract: Disclosed is a diazapan compound of formula (I) where the variables are as disclosed in the description. The compounds are suitable for melanocortin 5 receptor antagonists (MC5R). An example of a compound of formula (I) is 6-chloro-N-(([5,6,6-2H3](3S,5S)-2-oxo-1-((S)-2-phenylbutyl)-3-(2-(piperidin-1-yl)ethyl)-1 ,4-diazepan-5-yl)[2H2]methyl)-2-naphthamide. Also disclosed is a pharmaceutical composition containing a compound of formula (I).
Patent NZ-587480-A (NZ)
Title: Facilities for and method of separating and sorting livestock
Inventor: HULS MICHEL HUBERT JOHAN HENDRIK
IPC: A01K1/00
Filed: 2009-04-09
Abstract: Disclosed is an assembly consisting of a passageway (8) from a first space to a second space, delimited by side delimitations, for livestock, such as cattle. A gate system (3) is mounted in the passageway, the system having at least one self-closing gate leaf (6a, 6b) which is movable between a closed position and one or more open positions, including a pass position in which an animal can pass from the livestock passage to the second space. The gate leaf is arranged for movement to an open position by the exertion of pressure by an animal from the livestock passing through the passageway to the second space. The assembly is also provided with means (16) for determining an ID of an animal from the livestock, and in response to data from the ID determining means, means (7a, 7b) for blocking the gate leaf from moving into a pass position can be activated.
Patent NZ-590240-A (NZ)
Title: An interlocking connection means comprising a curved finger joint
Inventor: GLOVER DUNCAN
IPC: B27F1/00
Filed: 2010-12-24
Abstract: Inter-fitting first and second parts 2, 3, typically forming a container, have fingers and recesses of complementary shape so as to able to be locked together. The most outward part of each flared finger is the same width or is marginally wider than the entrance to the corresponding recess. However, a curve of the outer corner of the finger enables the finger to slide against and enter the recess.
Patent NZ-594527-A (NZ)
Title: Gate valve with lubricated secondary seal
Inventor: OHLSON ROBERT
IPC: F16K3/02
Filed: 2010-03-05
Abstract: A valve sealing member comprises a sealing member 60, 61 secured within a valve housing 11, the sealing member 60, 61 having a peripheral wall adapted to sealingly engage a valve closing member 14, an aperture 120 extending through the peripheral wall defining a channel which is configured to provide lubricating fluid to the valve closing member 14, and a dam 126 at least partially surrounding the aperture 120, the dam 126 having a lower portion angled away from a surface of the peripheral wall.
Patent NZ-595231-A (NZ)
Title: Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
Inventor: CATRON DREW M
IPC: A61K39/085
Filed: 2010-03-23
Abstract: NZ 595231 Disclosed is a composition comprising: an isolated polypeptide having at least 98% sequence similarity to the amino acid sequence of SEQ ID NO: 397, as defined in the complete specification, with the proviso that if the isolated polypeptide includes one or more additional amino acids at the amino terminal, the one or more additional amino acids include at least two amino acid modifications compared to amino acids 1-26 of SEQ ID NO: 399, as defined in the complete specification, wherein each amino acid modification comprises a deletion of an amino acid or an amino acid substitution; and at least one second polypeptide, wherein the second polypeptide is isolatable from a Staphylococcus aureus when incubated in media comprising an iron chelator and not isolatable when grown in the media without the iron chelator. Also disclosed is the use of an effective amount of a composition comprising an isolated polypeptide having at least 98% sequence similarity to the amino acid sequence of SEQ ID NO: 397, as defined in the complete specification, with the proviso that if the isolated polypeptide includes one or more additional amino acids at the amino terminal, the one or more additional amino acids include at least two amino acid modifications compared to amino acids 1-26 of SEQ ID NO: 399, as defined in the complete specification, wherein each amino acid modification comprises a deletion of an amino acid or an amino acid substitution, for the manufacture of a medicament for the treatment of an infection in a subject having or at risk of having an infection caused by a Staphylococcus spp.
Patent NZ-597581-A (NZ)
Title: Method and device for monitoring the state of a network
Inventor: BEEKMANN ALFRED
IPC: G01R19/25
Filed: 2010-06-23
Abstract: 597581 Disclosed is a method of detecting electric variables of a three-phase AC network having a first, a second and a third phase. The method includes measuring respective voltage values of the first, second and third phases in relation to a neutral conductor at a first moment in time and transforming the three voltage values of the first moment in time into polar co-ordinates having a voltage amplitude and a phase angle. The method also includes repeating the measurement and transformation for at least one further moment in time, and determining the currently prevailing frequency, voltage amplitude and/or phase angle of at least one of the phases from the voltage values transformed into polar co-ordinates.
Patent NZ-599540-A (NZ)
Title: System for providing a tailored investment option for apathetic investors
Inventor: BUCKNELL LIONEL
IPC: G06Q40/00
Filed: 2010-12-14
Abstract: Disclosed is a computer-implemented system for automatically deriving the appropriate investment option for each investor in a collective investment data pool. The system includes the means for processing available investor and market data, the means for computing a matrix of ‘hurdle levels’ (ie potential goals) across the whole pool of eligible investors, the means for setting ‘glide paths’ (i.e, percentage of growth assets at different ages) for each of these hurdles, the means for automatically providing asset allocations and advice to individual investors, and the means for providing asset allocations and advice to third party entities (eg a trustee organisation managing the investor’s fund). The system also includes least one an investor, controlling entity, investment option, style or type, hurdle level or similar asset goal, glide path or similar changing ratio of asset classes (e.g, growth versus income assets expressed over time, and end date balance (e,g, balance at withdrawal date).